87 related articles for article (PubMed ID: 9845140)
1. Increased tissue endothelin-1-like immunoreactivity in the internal mammary artery of patients with diabetes or hypercholesterolemia modulates the graft flow in the peri-operative period.
Göbel H; Ihling C; Dentz J; Schaefer HE; Zeiher AM; Fraedrich G
Eur J Cardiothorac Surg; 1998 Oct; 14(4):367-72. PubMed ID: 9845140
[TBL] [Abstract][Full Text] [Related]
2. Comparison of endothelium-dependent vasoactivity of internal mammary arteries from hypertensive, hypercholesterolemic, and diabetic patients.
Pompilio G; Rossoni G; Alamanni F; Tartara P; Barajon I; Rumio C; Manfredi B; Biglioli P
Ann Thorac Surg; 2001 Oct; 72(4):1290-7. PubMed ID: 11603450
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in vascular reactivity of coronary artery bypass graft conduits.
Jaghoori A; Lamin V; Jacobczak R; Worthington M; Edwards J; Viana F; Stuklis R; Wilson DP; Beltrame JF
Heart Vessels; 2020 Mar; 35(3):422-431. PubMed ID: 31576420
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels and vascular effects of endothelin and big endothelin in patients with stable and unstable angina pectoris undergoing coronary bypass grafting.
Lockowandt U; Bjessmo S; Ivert T; Franco-Cereceda A
Eur J Cardiothorac Surg; 2002 Feb; 21(2):218-23. PubMed ID: 11825727
[TBL] [Abstract][Full Text] [Related]
5. Diltiazem provides higher internal mammary artery flow than nitroglycerin during coronary artery bypass grafting surgery.
Tabel Y; Hepağuşlar H; Erdal C; Catalyürek H; Acikel U; Elar Z; Aslan O
Eur J Cardiothorac Surg; 2004 Apr; 25(4):553-9. PubMed ID: 15037271
[TBL] [Abstract][Full Text] [Related]
6. Location of the second internal mammary artery graft does not influence outcome of coronary artery bypass grafting.
Kurlansky PA; Traad EA; Dorman MJ; Galbut DL; Zucker M; Ebra G
Ann Thorac Surg; 2011 May; 91(5):1378-83; discussion 1383-4. PubMed ID: 21435631
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane A2: an endothelium-derived vasoconstrictor in human internal mammary arteries.
Lin PJ; Chang CH; Pearson PJ; Tzen KY; Chu JJ; Chang JP; Hsieh MJ
Ann Thorac Surg; 1993 Jul; 56(1):97-100. PubMed ID: 8328883
[TBL] [Abstract][Full Text] [Related]
8. Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression.
Sutherland AJ; Nataatmadja MI; Walker PJ; Cuttle L; Garlick RB; West MJ
Circulation; 2006 Mar; 113(9):1180-8. PubMed ID: 16505174
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin-1 receptor antagonists in vasoconstriction mediated by endothelin and other vasoconstrictors in human internal mammary artery.
He GW; Liu MH; Yang Q; Furnary A; Yim AP
Ann Thorac Surg; 2007 Nov; 84(5):1522-7. PubMed ID: 17954056
[TBL] [Abstract][Full Text] [Related]
10. Role of endothelin-1 in genesis of coronary artery disease.
Sainani GS; Maru VG; Mehra AP
Indian Heart J; 2005; 57(2):121-7. PubMed ID: 16013351
[TBL] [Abstract][Full Text] [Related]
11. Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial.
Harskamp RE; Alexander JH; Ferguson TB; Hager R; Mack MJ; Englum B; Wojdyla D; Schulte PJ; Kouchoukos NT; de Winter RJ; Gibson CM; Peterson ED; Harrington RA; Smith PK; Lopes RD
Circulation; 2016 Jan; 133(2):131-8. PubMed ID: 26647082
[TBL] [Abstract][Full Text] [Related]
12. The comparison of traditional and modified harvesting techniques of left ınternal mammary artery regarding endothelin-1/2/3 expression and free flow capacity.
Buyukates M; Barut F; Aktunc E
J Cardiovasc Surg (Torino); 2015 Dec; 56(6):913-8. PubMed ID: 24647318
[TBL] [Abstract][Full Text] [Related]
13. Middle and proximal sections of the human internal mammary artery are not "passive conduits".
He GW; Acuff TE; Yang CQ; Ryan WH; Mack MJ
J Thorac Cardiovasc Surg; 1994 Oct; 108(4):741-6. PubMed ID: 7934111
[TBL] [Abstract][Full Text] [Related]
14. Quicker yet safe: skeletonization of 1640 internal mammary arteries with harmonic technology in 965 patients.
Kieser TM; Rose MS; Aluthman U; Narine K
Eur J Cardiothorac Surg; 2014 May; 45(5):e142-50. PubMed ID: 24574446
[TBL] [Abstract][Full Text] [Related]
15. In Situ Skeletonized Right Internal Mammary Artery Bypass Grafting to Left Anterior Descending Artery.
Ji Q; Xia L; Shi Y; Ma R; Shen J; Lai H; Ding W; Wang C
Int Heart J; 2018 Jan; 59(1):35-42. PubMed ID: 29279526
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies on internal mammary artery bypass grafts. Action of endogenous and exogenous vasodilators and vasoconstrictors.
Evora PR; Pearson PJ; Discigil B; Oeltjen MR; Schaff HV
J Cardiovasc Surg (Torino); 2002 Dec; 43(6):761-71. PubMed ID: 12483164
[TBL] [Abstract][Full Text] [Related]
17. Influence of diabetes and mammary artery grafting on survival after coronary bypass.
Morris JJ; Smith LR; Jones RH; Glower DD; Morris PB; Muhlbaier LH; Reves JG; Rankin JS
Circulation; 1991 Nov; 84(5 Suppl):III275-84. PubMed ID: 1934420
[TBL] [Abstract][Full Text] [Related]
18. Single versus multiple internal mammary artery grafting for coronary artery bypass: 15-year follow-up of a clinical practice trial.
Burfeind WR; Glower DD; Wechsler AS; Tuttle RH; Shaw LK; Harrell FE; Rankin JS
Circulation; 2004 Sep; 110(11 Suppl 1):II27-35. PubMed ID: 15364834
[TBL] [Abstract][Full Text] [Related]
19. Quantitative measurement of endothelium derived nitric oxide production of the internal mammary artery bypass graft during extracorporeal circulation.
Tarr FI; Sasvári M; Dudás G; Kroó M; Somogyi A; Tomcsányi I
Eur J Cardiothorac Surg; 2001 May; 19(5):653-6. PubMed ID: 11343947
[TBL] [Abstract][Full Text] [Related]
20. Internal mammary hypoperfusion syndrome--diagnosis and treatment.
Caldeira CC; Char EA; Caldeira AS; Moreno-Cabral CE; McNamara JJ
Jpn Circ J; 1997 Dec; 61(12):1011-4. PubMed ID: 9412865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
